bucladesine has been researched along with MS (Multiple Sclerosis) in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baer, A; Franklin, RJ; González, GA; Hofer, MP; Huang, JK; Kotter, MR; Lubec, G; Myrta, S; Rossner, MJ; Rundle, J; Syed, YA; Trotter, MW; Zhao, C | 1 |
Giorelli, M; Livrea, P; Trojano, M | 1 |
Dinter, H; Martin, R; McFarland, HF; Muraro, PA; Pette, DF; Pette, M | 1 |
Comabella, M; Imitola, J; Khoury, SJ; Makhlouf, K; Weiner, HL | 1 |
Barna, BP; Estes, ML; Jacobs, BS; McMahon, JT; Ransohoff, RM | 1 |
5 other study(ies) available for bucladesine and MS (Multiple Sclerosis)
Article | Year |
---|---|
Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination.
Topics: Animals; Bucladesine; Cell Differentiation; Cells, Cultured; Central Nervous System; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Immunity, Innate; Mitogen-Activated Protein Kinases; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Phosphodiesterase 4 Inhibitors; Rats; Rats, Sprague-Dawley; Transcriptome | 2013 |
Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients.
Topics: Adrenergic beta-Agonists; Adult; beta-Adrenergic Receptor Kinases; Bucladesine; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Female; Humans; Interferon-gamma; Isoproterenol; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Neuroimmunomodulation; Receptors, Adrenergic, beta-2; Signal Transduction; Up-Regulation | 2004 |
Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Antibodies; Autoantigens; Bucladesine; Cell Division; Clone Cells; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Interleukin-10; Interleukin-2; Lymphotoxin-alpha; Multiple Sclerosis; Myelin Proteins; Myelin Sheath; Oligonucleotide Probes; Phosphodiesterase Inhibitors; Pyrrolidinones; Receptors, Interleukin-2; RNA, Messenger; Rolipram; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1999 |
Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; B7-1 Antigen; Bucladesine; CD40 Antigens; Dendritic Cells; Female; Humans; Interleukin-12; Lipopolysaccharides; Male; Middle Aged; Monocytes; Multiple Sclerosis | 2001 |
Characterization of adult human astrocytes derived from explant culture.
Topics: Adult; Astrocytes; Bromodeoxyuridine; Bucladesine; Cell Line; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; Microscopy, Electron; Multiple Sclerosis | 1990 |